Senior Director, Early Partnerships & Transactions Lead
Posted 1 month ago Expired
This job has expired
Looking for a job like Senior Director, Early Partnerships & Transactions Lead in or near King of Prussia, PA? Upload your resume and we'll notify you when similar positions become available.
Upload Your ResumeAbout This Role
Lead early-stage external innovation deals for CSL's R&D organization, focusing on MTAs, research collaborations, and creative partnership structures to accelerate the onboarding and advancement of external assets.
Responsibilities
- Drive MTAs, research collaborations, options-to-license, and other innovative structures to accelerate external innovation
- Partner with big pharma BD teams to identify and onboard deprioritized assets
- Maintain strong relationships with academia, biotech, and investors
- Create onboarding advantages and transaction pathways that position the organization as a preferred partner
- Communicate deal vision and strategic rationale internally
- Collaborate with BD to amplify priorities to banks, VCs, and the investment community
- Design new partnership and funding approaches to expand deal-making capabilities
- Set success metrics, monitor progress, and deliver value through disciplined execution for early partnerships
Requirements
- 15+ years in biopharma business development, alliance management, or external innovation roles
- 10+ years in senior leadership positions
- Demonstrated success in structuring and closing complex deals, including early-stage collaborations and creative funding models
- Strong network within pharma BD organizations, biotech, and investment communities
- Exceptional negotiation, relationship-building, and strategic thinking skills
Qualifications
- Advanced degree preferred (MBA, PhD, or equivalent)
- 15+ years in biopharma business development, alliance management, or external innovation roles, with 10+ years in senior leadership positions
About BioSpace
Lilly is a global healthcare leader headquartered in Indianapolis, Indiana, specializing in discovering and bringing life-changing medicines to patients worldwide. They are investing over $1 billion to create a new state-of-the-art manufacturing site in Concord, NC, focusing on parenteral medication...